TriangleFOR PATIENTS · SOURCE READING
Treatment of Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Source: Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Treatment of localized transitional cell cancer of the renal pelvis and ureter may include:
Source links and citations
surgery (nephroureterectomy or segmental resection of ureter)
Source links and citations
a clinical trial of fulguration
Source links and citations
a clinical trial of laser surgery
Source links and citations
a clinical trial of segmental resection of the renal pelvis
a clinical trial of regional chemotherapy or regional immunotherapy
Source links and citations
To learn more about these treatments, see the Treatment Option Overview.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice